Lymph node-positive prostate cancer: Current issues, emerging technology and impact on clinical outcome

Julia Adams, Liang Cheng

Research output: Contribution to journalReview article

8 Scopus citations


Lymph node metastasis in patients with prostate cancer indicates a poorer prognosis compared with patients without lymph node metastasis; however, some patients with node-positive disease have long-term survival. Many studies have attempted to discern what characteristics of lymph node metastasis are prognostically significant. These characteristics include nodal tumor volume, number of positive lymph nodes, lymph node density, extranodal extension, lymphovascular invasion and tumor dedifferentiation. Favorable characteristics of regional lymph node involvement included a smaller tumor size and smaller tumor volume. However, the current staging system for prostate cancer does not provide different subclassifications for patients with node-positive prostate cancer. In recent years numerous advanced technologies for the detection of lymph node metastasis have been developed, including molecular imaging techniques and the CellSearch ® Circulating Tumor Cell System. With the increased detection of patients with prostate cancer, emergence of new technology to identify lymph node metastasis and the number of radical prostatectomies being performed on the rise, subclassifying patients with lymph node-positive disease is imperative. Subclassification would provide a better picture of patient prognosis and allow for a better understanding of targeted therapies to treat patients with lymph node metastasis.

Original languageEnglish (US)
Pages (from-to)1457-1469
Number of pages13
JournalExpert Review of Anticancer Therapy
Issue number9
StatePublished - Sep 1 2011


  • cancer volume
  • dedifferentiation
  • metastasis
  • pelvic lymphadenectomy
  • prognosis
  • prostate
  • sentinel node
  • staging and classification

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Fingerprint Dive into the research topics of 'Lymph node-positive prostate cancer: Current issues, emerging technology and impact on clinical outcome'. Together they form a unique fingerprint.

  • Cite this